Vale SA (ADR) (VALE) Analysts See $0.25 EPS, Ariel Investments Has Boosted Its Johnson & Johnson (JNJ) Stake

July 5, 2017 - By Darrin Black

Analysts expect Vale SA (ADR) (NYSE:VALE) to report $0.25 EPS on July, 27.They anticipate $0.11 EPS change or 78.57% from last quarter’s $0.14 EPS. VALE’s profit would be $1.30B giving it 8.64 P/E if the $0.25 EPS is correct. After having $0.41 EPS previously, Vale SA (ADR)’s analysts see -39.02% EPS growth. About 7.40M shares traded. Vale SA (ADR) (NYSE:VALE) has risen 111.11% since July 5, 2016 and is uptrending. It has outperformed by 94.41% the S&P500.

Ariel Investments Llc increased Johnson & Johnson (JNJ) stake by 1.38% reported in 2016Q4 SEC filing. Ariel Investments Llc acquired 11,810 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Ariel Investments Llc holds 870,359 shares with $100.27M value, up from 858,549 last quarter. Johnson & Johnson now has $360.18 billion valuation. The stock rose 0.14% or $0.19 reaching $133.09 per share. About 509,760 shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since July 5, 2016 and is uptrending. It has underperformed by 4.16% the S&P500.

Vale S.A. is a global producer of iron ore and iron ore pellets, key raw materials for steelmaking, and producer of nickel. The company has market cap of $44.97 billion. The Firm also produces copper, metallurgical and thermal coal, potash, phosphates and other fertilizer nutrients, manganese ore, ferroalloys, platinum group metals, gold, silver and cobalt. It has a 7.63 P/E ratio.

Among 23 analysts covering Vale S.A. (NYSE:VALE), 9 have Buy rating, 1 Sell and 13 Hold. Therefore 39% are positive. Vale S.A. had 46 analyst reports since August 3, 2015 according to SRatingsIntel. The firm has “Buy” rating by HSBC given on Wednesday, October 28. The firm earned “Strong-Buy” rating on Wednesday, September 2 by Vetr. The stock of Vale SA (ADR) (NYSE:VALE) earned “Outperform” rating by Itau BBA on Thursday, October 20. The stock of Vale SA (ADR) (NYSE:VALE) earned “Buy” rating by Canaccord Genuity on Friday, September 4. As per Monday, January 9, the company rating was upgraded by Barclays Capital. On Tuesday, October 20 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm has “Neutral” rating by UBS given on Monday, October 19. The company was maintained on Friday, May 6 by RBC Capital Markets. The firm earned “Neutral” rating on Tuesday, November 1 by Citigroup. As per Tuesday, August 9, the company rating was upgraded by Morgan Stanley.

Among 16 analysts covering Johnson & Johnson (NYSE:JNJ), 8 have Buy rating, 1 Sell and 7 Hold. Therefore 50% are positive. Johnson & Johnson had 44 analyst reports since August 7, 2015 according to SRatingsIntel. The firm earned “Hold” rating on Thursday, August 4 by Jefferies. The stock has “Buy” rating by Deutsche Bank on Tuesday, September 29. Barclays Capital downgraded the shares of JNJ in report on Tuesday, November 29 to “Equal-Weight” rating. The firm has “Sell” rating given on Friday, May 20 by Standpoint Research. The rating was maintained by RBC Capital Markets with “Outperform” on Wednesday, July 20. The stock has “Overweight” rating by Barclays Capital on Wednesday, April 20. The rating was maintained by Jefferies on Tuesday, March 15 with “Hold”. The stock has “Hold” rating by Jefferies on Tuesday, September 13. The firm has “Neutral” rating by Goldman Sachs given on Monday, March 14. The company was maintained on Wednesday, January 25 by RBC Capital Markets.

Since February 1, 2017, it had 0 insider purchases, and 5 sales for $14.98 million activity. The insider Stoffels Paulus sold 22,000 shares worth $2.58 million. Shares for $1.99 million were sold by Pruden Gary J. 14,543 shares were sold by Kapusta Ronald A, worth $1.78 million. Duato Joaquin also sold $6.18 million worth of Johnson & Johnson (NYSE:JNJ) on Friday, March 3. 21,735 Johnson & Johnson (NYSE:JNJ) shares with value of $2.45M were sold by Ullmann Michael H.

Investors sentiment increased to 0.94 in 2016 Q4. Its up 0.12, from 0.82 in 2016Q3. It improved, as 63 investors sold JNJ shares while 834 reduced holdings. 114 funds opened positions while 731 raised stakes. 1.72 billion shares or 0.88% more from 1.71 billion shares in 2016Q3 were reported. Pictet Asset Limited holds 2.03M shares. Manufacturers Life Ins Company The has invested 0.91% in Johnson & Johnson (NYSE:JNJ). Livforsakringsbolaget Skandia Omsesidigt has 1.67% invested in Johnson & Johnson (NYSE:JNJ). Shufro Rose & has 42,786 shares for 0.55% of their portfolio. Moreover, Highvista Strategies Ltd has 0.16% invested in Johnson & Johnson (NYSE:JNJ) for 7,200 shares. 155,088 were accumulated by Nbt Comml Bank N A Ny. Massmutual Tru Co Fsb Adv, a Connecticut-based fund reported 133,907 shares. Ami Mgmt invested in 37,559 shares or 2.87% of the stock. Ohio-based Inv Partners Limited Oh Adv has invested 1.91% in Johnson & Johnson (NYSE:JNJ). Vista Prns holds 0.08% of its portfolio in Johnson & Johnson (NYSE:JNJ) for 2,534 shares. Calamos Wealth Mngmt Ltd stated it has 1.15% of its portfolio in Johnson & Johnson (NYSE:JNJ). Sandy Spring Bancshares reported 112,830 shares or 1.36% of all its holdings. Incorporated Ok stated it has 135,151 shares. New Vernon Management Lc has 5,442 shares for 0.87% of their portfolio. Ferguson Wellman Capital Mngmt holds 0.85% or 181,605 shares in its portfolio.